M. Van de Putte

The impact of aggregation on the biodistribution of hypericin.

G. Bormans, T. Roskams, A. Verbruggen, 2006, International journal of oncology.

Evaluation of tumor affinity of mono-[(123)I]iodohypericin and mono-[(123)I]iodoprotohypericin in a mouse model with a RIF-1 tumor.

Y. Ni, G. Bormans, A. Verbruggen, 2007, Contrast media & molecular imaging.

Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential

Y. Ni, G. Bormans, T. Roskams, 2012, International journal of cancer.

Exploration of the mechanism underlying the tumor necrosis avidity of hypericin.

Y. Ni, P. D. de Witte, M. Van de Putte, 2008, Oncology reports.

Elucidation of the tumoritropic principle of hypericin

T. Roskams, P. Agostinis, P. D. de Witte, 2005, British Journal of Cancer.

Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model.

Feng Chen, Yicheng Ni, Huaijun Wang, 2008, Academic radiology.

Hypericin as a marker for determination of tissue viability after radiofrequency ablation in a murine liver tumor model.

Feng Chen, Yicheng Ni, Huaijun Wang, 2008, Oncology reports.

Immunofunctional properties of a yolk sac epithelial cell line expressing two proteins gp280 and gp330 of the intermicrovillar area of proximal tubule cells: inhibition of endocytosis by the specific antibodies.

P. Verroust, M. Galcerán, M. Van de Putte, 1995, European journal of cell biology.